20
Ctx Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CARBAMAZEPINE USP, with a corresponding US DMF Number 24195.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 07, 2013, and payment made on February 15, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II